Table 3 Associations between markers and chemotherapy response.
Variable | Â | Complete vs. other | Complete/Partial vs. other | Other vs. progression | ||||||
---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value | ||
CD68 | Low vs. high | 0.72 | 0.27–1.91 | 0.50 | 1.13 | 0.42–3.023 | 0.81 | 1.63 | 0.52–5.078 | 0.40 |
Continuous | 0.33 | 0.58 | 0.97 | |||||||
MAC387 | Low vs. high | 0.94 | 0.36–2.49 | 0.91 | 1.038 | 0.39–2.77 | 0.94 | 1.48 | 0.49–4.46 | 0.48 |
Continuous | 0.42 | 0.40 | 0.53 | |||||||
MAC387tumor1 | Low vs. high | 3.57 | 0.90–14.13 | 0.070* | 3.18 | 0.97–10.37 | 0.056* | 3.76 | 1.10–12.82 | 0.034* |
All groups 0–3 | 0.41 | 0.36 | 0.40 | |||||||
CLEVER-1m2 | Low vs. high | 1.63 | 0.62–4.32 | 0.33 | 2.78 | 1.006–7.67 | 0.049* | 1.61 | 0.53–4.88 | 0.40 |
Continuous | 0.49 | 0.21 | 0.88 | |||||||
CLEVER-1v3 | Low vs. high | 0.99 | 0.37–2.62 | 0.98 | 0.76 | 0.28–2.050 | 0.58 | 0.47 | 0.14–1.52 | 0.21 |
Continuous | 0.26 | 0.10 | 0.012* |